“This large-scale study demonstrates the significant benefits for people managing low back pain when using Kaia to deliver a multimodal treatment through a digital device, such as a smartphone," says Thomas R. Toelle, M.D., Ph.D., head of the Pain Center of the Technical University Munich, Germany. “These results add to the growing body of medical evidence that supports the use of digital multimodal treatments for chronic conditions, such as back pain.”
According to Kaia Health, low back pain is one of the leading causes of global disability, with an enormous cost for healthcare systems worldwide.1,2 According to a 2018 report on the impact of musculoskeletal pain on employers, chronic pain, including back pain, accounts for 188.7 million lost work days, and $62.4 billion in lost productivity cost.3
"COVID is changing the way that health care is delivered and driving a meaningful increase in demand for multimodal virtual therapy solutions. We’re focused on the highest level of clinical rigor to protect the health of patients, and significantly improve their chronic pain; remotely, effectively and at scale,” says Kaia founder and president, Konstantin Mehl. “Companies looking to integrate digital back pain therapy into their health plan for employees can trust that the Kaia treatment is medically sound.”
Also, Kaia Health recently announced news of a $26 million Series B funding, which included new investments from top healthcare VC Optum Ventures and world number one ranked Golfer Rory McIlroy.
1 Dalys, G. B. D. & Collaborators, H. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390, 1260–1344 (2017).
2 Maher, C., Underwood, M. & Buchbinder, R. Non-specific low back pain. Lancet 389, 736–747 (2017).
3 The impact of musculoskeletal pain on employers (2018)